Heart Attack
Researchers' findings from Japan and Greece advance heart attack research
Published in Blood Weekly, October 5th, 2006
Study 1: Canine myocardial infarction (MI) models show erythropoietin (EPO) enhances cardiac tissue neovascularization.
According to recent research from Japan, "We investigated the effects of EPO on neovascularization and cardiac function after MI. Erythropoietin exerts antiapoptotic effects and mobilizes endothelial progenitor cells (EPCs)."
"We intravenously administered EPO (1,000 IU/kg) immediately [EPO(0) group], 6 h [EPO(6 h) group], or 1 week [EPO(1 wk) group] after the permanent ligation of the coronary artery in dogs. Control animals received saline...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2006-10-05)
More Articles from Blood Weekly
- Blood Safety
Pall System to detect bacteria in red blood cells granted CE Mark - Blood Safety
Safety concerns over the Canadian blood supply drives patients to autodonate - Blood Safety
Simian foamy virus infection occurred by whole-blood transfer in rhesus macaques - Tissue Engineering
Porous micro-patterned scaffold developed for vascular tissue engineering - Tissue Engineering
Tissue-engineered tooth produced by embryonic tooth germ cells in 3-dimensional scaffold - Alzheimer Disease
Selective Alzheimer Disease Indicator-1 gene abundantly expressed by stem cells - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
